C1QTNF3 and androgen insensitivity syndrome: Wang Le et al concluded that miR-409-3P could inhibit the expression of CTRP3 in PC12 cells, and serum miR-409-3P was correlated with the severity of AIS, which was clinically significant as a molecular marker for the early diagnosis of AIS.